Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response

Blood Cells Mol Dis. 2021 Sep:90:102576. doi: 10.1016/j.bcmd.2021.102576. Epub 2021 May 11.
No abstract available

Keywords: Biomarkers; Hydroxyurea; MCHC; Sickle cell anemia.

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell* / blood
  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents* / administration & dosage
  • Antisickling Agents* / pharmacokinetics
  • Biomarkers / blood
  • Child
  • Child, Preschool
  • Erythrocytes / metabolism*
  • Female
  • Hemoglobin, Sickle / metabolism*
  • Humans
  • Hydroxyurea* / administration & dosage
  • Hydroxyurea* / pharmacokinetics
  • Infant
  • Male

Substances

  • Antisickling Agents
  • Biomarkers
  • Hemoglobin, Sickle
  • Hydroxyurea

Associated data

  • ClinicalTrials.gov/NCT02286154